List of Excipients in API TERAZOSIN HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing TERAZOSIN HYDROCHLORIDE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Sandoz Inc | terazosin hydrochloride | 0781-2051 | CELLULOSE, MICROCRYSTALLINE |
| Sandoz Inc | terazosin hydrochloride | 0781-2051 | CROSPOVIDONE |
| Sandoz Inc | terazosin hydrochloride | 0781-2051 | D&C YELLOW NO. 10 |
| Sandoz Inc | terazosin hydrochloride | 0781-2051 | FD&C BLUE NO. 1 |
| Sandoz Inc | terazosin hydrochloride | 0781-2051 | FD&C BLUE NO. 2 |
| Sandoz Inc | terazosin hydrochloride | 0781-2051 | FD&C RED NO. 40 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for TERAZOSIN HYDROCHLORIDE
Excipient focus: ANHYDROUS LACTOSE
TERAZOSIN HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | terazosin hydrochloride anhydrous | 0378-2260 |
| Mylan Institutional Inc | terazosin hydrochloride anhydrous | 51079-936 |
| Bryant Ranch Prepack | terazosin hydrochloride anhydrous | 71335-0787 |
| >Company | >Ingredient | >NDC |
TERAZOSIN HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
TERAZOSIN HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
TERAZOSIN HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CI 77891
TERAZOSIN HYDROCHLORIDE drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | terazosin hydrochloride | 50090-0657 |
| >Company | >Ingredient | >NDC |
TERAZOSIN HYDROCHLORIDE drug variants not containing CI 77891
Excipient focus: COLLOIDAL SILICON DIOXIDE
TERAZOSIN HYDROCHLORIDE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | terazosin hydrochloride | 21695-812 |
| State of Florida DOH Central Pharmacy | terazosin hydrochloride | 53808-1056 |
| >Company | >Ingredient | >NDC |
TERAZOSIN HYDROCHLORIDE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
TERAZOSIN HYDROCHLORIDE drug variants containing CROSPOVIDONE
TERAZOSIN HYDROCHLORIDE drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 28
TERAZOSIN HYDROCHLORIDE drug variants containing D&C RED NO. 28
TERAZOSIN HYDROCHLORIDE drug variants not containing D&C RED NO. 28
Excipient focus: D&C RED NO. 33
TERAZOSIN HYDROCHLORIDE drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | terazosin hydrochloride anhydrous | 0378-2260 |
| Mylan Institutional Inc | terazosin hydrochloride anhydrous | 51079-936 |
| Bryant Ranch Prepack | terazosin hydrochloride anhydrous | 71335-0787 |
| >Company | >Ingredient | >NDC |
TERAZOSIN HYDROCHLORIDE drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
TERAZOSIN HYDROCHLORIDE drug variants containing D&C YELLOW NO. 10
TERAZOSIN HYDROCHLORIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
TERAZOSIN HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1
TERAZOSIN HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
TERAZOSIN HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
TERAZOSIN HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C GREEN NO. 3
TERAZOSIN HYDROCHLORIDE drug variants containing FD&C GREEN NO. 3
TERAZOSIN HYDROCHLORIDE drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 40
TERAZOSIN HYDROCHLORIDE drug variants containing FD&C RED NO. 40
TERAZOSIN HYDROCHLORIDE drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE YELLOW
TERAZOSIN HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | terazosin hydrochloride anhydrous | 0378-2260 |
| Mylan Institutional Inc | terazosin hydrochloride anhydrous | 51079-936 |
| Bryant Ranch Prepack | terazosin hydrochloride anhydrous | 71335-0787 |
| >Company | >Ingredient | >NDC |
TERAZOSIN HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
TERAZOSIN HYDROCHLORIDE drug variants containing FERROSOFERRIC OXIDE
TERAZOSIN HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
TERAZOSIN HYDROCHLORIDE drug variants containing GELATIN
TERAZOSIN HYDROCHLORIDE drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
TERAZOSIN HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
TERAZOSIN HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | terazosin hydrochloride anhydrous | 0378-2260 |
| Mylan Institutional Inc | terazosin hydrochloride anhydrous | 51079-936 |
| Bryant Ranch Prepack | terazosin hydrochloride anhydrous | 71335-0787 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
TERAZOSIN HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
TERAZOSIN HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
TERAZOSIN HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
TERAZOSIN HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
TERAZOSIN HYDROCHLORIDE drug variants containing SHELLAC
TERAZOSIN HYDROCHLORIDE drug variants not containing SHELLAC
Excipient focus: SILICA
TERAZOSIN HYDROCHLORIDE drug variants containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | terazosin hydrochloride | 50090-0657 |
| >Company | >Ingredient | >NDC |
TERAZOSIN HYDROCHLORIDE drug variants not containing SILICA
Excipient focus: SILICON DIOXIDE
TERAZOSIN HYDROCHLORIDE drug variants containing SILICON DIOXIDE
TERAZOSIN HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
TERAZOSIN HYDROCHLORIDE drug variants containing SODIUM LAURYL SULFATE
TERAZOSIN HYDROCHLORIDE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
TERAZOSIN HYDROCHLORIDE drug variants containing STARCH, CORN
TERAZOSIN HYDROCHLORIDE drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
TERAZOSIN HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
TERAZOSIN HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | terazosin hydrochloride | 50090-0657 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links